Search the Newsreel

August 2026's Top Growth Picks With Insider Confidence

This article identifies top growth companies in the United States for August 2026 that also exhibit high insider ownership, suggesting strong internal confidence. It highlights PDF Solutions, Upstart Holdings, and Riskified as notable picks, detailing their financial performance, growth forecasts, and insider ownership percentages. …

3 Reasons UPST Has Explosive Upside Potential

3 Reasons UPST Has Explosive Upside Potential Over the past six months, Upstart's shares (currently trading at $30.16) have posted a disappointing 8.9% loss, well below the S&P 500's 11.7% gain. This was partly due to its softer quarterly results and may have investors …

91% of Upstart's Loans Were Fully Automated Last Quarter. No Bank Can Underwrite That Cheaply.

Key Points Shares of Upstart have slumped about 31% year to date. The bank had a strong Q2 with 91% of its loan originations handled by AI. Upstart recently got approval for a bank charter, which should improve its unit economics. 10 stocks we …

Truist Financial Maintains UpStream Bio(UPB.US) With Buy Rating, Maintains Target Price $25

Truist Financial has reiterated its Buy rating for UpStream Bio (UPB.US) and maintained its target price at $25. This indicates the firm's continued positive outlook on the company's stock performance.

A Quick Look at Today's Ratings for UpStream Bio(UPB.US), With a Forecast Between $19 to $36

This article provides a quick look at today's analyst ratings for UpStream Bio (UPB.US), noting a forecast price range between $19 and $36. It indicates that these ratings are based on the average price targets set by various financial analysts.

Q2 2026 Upstart Holdings Inc Earnings Call Transcript

Upstart Holdings Inc (UPST) reported strong Q2 2026 results, with originations up 50% year-over-year and a return to GAAP profitability. The company secured significant institutional funding, and its AI model continues to outperform traditional credit scoring. Despite macroeconomic headwinds and the discontinuation of its …

Upstart Investors Sue Over an AI Model That Quietly Rejected Borrowers

Upstart Holdings is facing a securities fraud class action lawsuit alleging that executives concealed the fact its Model 22 AI underwriting system was quietly rejecting borrowers, even as they provided positive revenue guidance. Investors claim the company overstated Model 22's accuracy and ability to …

How Strong Q2 Results And New Castlelake Loan Pact At Upstart (UPST) Has Changed Its Investment Story

UPST: Record Q2 profits and strategic focus on core lending signal a new phase of AI-driven growth

Upstart Holdings, Inc. (UPST) reported record Q2 profits, driven by strong performance in core personal loans and improved margins in secured products. The company is undergoing a leadership transition and renewed focus on contribution profit, addressing investor concerns about capital efficiency and operating leverage. …

Transcript : Upstart Holdings, Inc. Presents at Bank of America SMID Cap Virtual Conference, Aug-11-2026 11

Upstream Bio (UPB) Earnings Date and Reports 2026 $UPB

Upstream Bio (UPB) announced its Q2 2026 earnings on August 11, 2026, reporting an EPS of -$0.73, beating analyst estimates by $0.01. The company also exceeded revenue expectations with $0.77 million against an estimated $0.56 million. Despite beating estimates, Upstream Bio's earnings are projected …

Upstream Bio (NASDAQ:UPB) Announces Quarterly Earnings Results, Beats Expectations By $0.05 EPS

Upstream Bio (NASDAQ:UPB) announced its quarterly earnings, reporting an adjusted loss of $0.73 per share, surpassing analyst expectations of a $0.78 loss by $0.05. The company also exceeded revenue forecasts, reaching $0.77 million against an expected $0.43 million. Despite beating estimates, Upstream Bio remains …

Upstream Bio, Inc. (UPB) Reports Q2 Loss, Tops Revenue Estimates

Upstream Bio posts corporate presentation highlighting verekitug Phase 3 plans in severe asthma, CRSwNP

Upstream Bio has released a corporate presentation detailing its plans for verekitug, a TSLP receptor antagonist, including a mid-2026 FDA meeting and Phase 3 trials in severe asthma and CRSwNP targeting Q1 2027. The company's pipeline shows promising Phase 2 data for verekitug in …

Form 8K Upstream Bio Inc For: 11 August By Investing.com

This article announces that Upstream Bio Inc. has filed a Form 8K on August 11, with its stock symbol UPB showing a 2.22% increase. The content provided is primarily a placeholder for this financial filing, with minimal specific details about the 8K's contents. It …

Upstream Bio, Inc. 2Q 2026: Revenue $0.8M, EPS $(0.73) — 10-Q Summary

Upstream Bio, Inc. reported its second-quarter 2026 results, showing revenue of $0.8M and a net loss of $39.7M, resulting in a diluted EPS of $(0.73), which is largely consistent with the previous year. The company highlighted clinical progress for Verekitug in severe asthma and …

Upstream Bio (UPB) deepens R&D spend but ends quarter with $261M cash

Upstream Bio (NASDAQ: UPB) reports Q2 2026 loss and advances Phase 3 plans

Upstream Bio (NASDAQ: UPB) reported a Q2 2026 net loss of $39.7 million, similar to the previous year, with cash reserves of $261.3 million expected to fund operations through 2027. The company is advancing its lead asset, verekitug, towards Phase 3 trials for severe …

Upstream Bio Reports Second Quarter 2026 Financial Results and Highlights Continued Progress

Upstream Bio announced its second-quarter 2026 financial results, highlighting significant progress in developing verekitug for severe inflammatory respiratory diseases. The company is on track to initiate Phase 3 trials for severe asthma and CRSwNP in Q1 2027 and has completed enrollment for its Phase …

Is Upstart Holdings (UPST) Cheap On Stronger Earnings And A $4b Castlelake Deal?

UPST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds

Bronstein, Gewirtz and Grossman, LLC has filed a class action lawsuit against Upstart Holdings, Inc. (NASDAQ:UPST) and some of its officers. The lawsuit alleges that Upstart made false and misleading statements regarding its AI underwriting model's accuracy and impact on revenue. Investors who purchased …

Why Upstart Stock Plunged 23% in July

Key Points High interest rates and concerns about software-as-a-service stocks in the agentic AI era have weighed on Upstart stock. Upstart delivered solid performance in the second quarter, with a 42% year-over-year increase in revenue and positive net income. Management says it has an …

Upstart Holdings (UPST) Is Up 5.8% After $4 Billion Loan Pact And Conditional Bank Approval

Upstart Holdings (UPST) saw its stock rise by 5.8% following two significant announcements: a new $4 billion forward-flow agreement with Castlelake-managed funds for consumer loan purchases, and conditional approval from the Office of the Comptroller of the Currency to establish a nationwide, AI-driven digital …

Upstream Bio Inc (UPB) Earnings Forecast: Future EPS & Revenue Growth Estimates

Upstream Bio Inc (UPB) has an earnings forecast score of 7.78, ranking 268th in the Biotechnology & Medical Research industry. Analysts project an average price target of $43.00, with a strong "Buy" rating based on 9 analysts. The company's expected revenue for the next …

Upstart (UPST) Stock Still Looks Pricey Following Its 82% Five Year Slump

Upstart Holdings (UPST) stock has seen an 82.4% decline over the last five years, yet traditional valuation metrics still suggest it is expensive. The company's P/E ratio of 48.7x is significantly higher than the industry average, indicating overvaluation even after recent banking and funding …

Upstart Holdings, Inc. $UPST Shares Purchased by Dimensional Fund Advisors LP

Dimensional Fund Advisors LP significantly increased its stake in Upstart Holdings, Inc. (NASDAQ:UPST) during the first quarter, purchasing 744,190 additional shares to own over 1 million shares valued at approximately $26.2 million. This comes as Upstart reported strong second-quarter revenue growth, exceeding analyst expectations, …

Arrowstreet Capital Limited Partnership Buys New Holdings in Upstream Bio, Inc. $UPB

These Analysts Increase Their Forecasts On Upstart After Upbeat Q2 Results

Upstart Holdings (NASDAQ: UPST) reported strong second-quarter results, exceeding revenue estimates and affirming its FY2026 sales guidance. Following the upbeat performance, analysts from Piper Sandler and Needham both increased their price targets for the stock, maintaining their Overweight and Buy ratings, respectively. The company's …

Upstart’s Q2 auto loan originations surge 264% YoY

Upstart, an AI-based fintech, significantly increased its auto loan originations in Q2 2026, reaching $426 million, a 264.1% year-over-year increase. The company decided to discontinue its auto refinance business to concentrate on more promising areas of its portfolio and has also received conditional approval …

4 reasons Upstart beat on earnings: AI is the 'central premise,' CEO says

Paul Gu, CEO and co-founder of personal loan company Upstart (UPST), explains why the company's second quarter was so strong. Video Transcript 00:00 Speaker A originations uh jumped 50%, revenue rising 42%, company returned to gap profitability. Walk walk us through Paul what you …

Upstart Holdings, Inc. Stock 12‑Month Price Target Raised to $39.62, Implies 31% Upside

Upstart Holdings, Inc.'s average 12-month price target has been increased to $39.62 by 16 analysts, representing a potential upside of approximately 31% from its August 4th closing price. The consensus rating from 17 analysts remains a "Buy," with a breakdown of 9 Buys, 6 …

Upstart Stock Rises as Loan Volume Outgrows Its Margins

This article first appeared on GuruFocus. Upstart Holdings (NASDAQ:UPST) rose 5.44% intraday after the AI lending marketplace, which routes borrowers to more than 100 banks and credit unions, reported second-quarter originations of $4.23 billion, up 50% from a year earlier. Total revenue reached $364.7 …

Why Upstart Stock Was Climbing Today

Shares of Upstart (NASDAQ: UPST) were moving higher today after the AI-driven loan origination platform posted better-than-expected results in its second-quarter earnings report. As of 10:22 a.m. ET, the stock was up 6.6% after gaining as much as 13.8% earlier in the session. Missed …